{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:25:32Z","timestamp":1793424332189,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T00:00:00Z","timestamp":1710633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013807","name":"Wuhan University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","award":["2022IIT1163"],"award-info":[{"award-number":["2022IIT1163"]}],"id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijantimicag.2024.107152","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T16:40:48Z","timestamp":1710866448000},"page":"107152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of ceftazidime-avibactam in the treatment of carbapenem-resistant Klebsiella pneumoniae infections: Focus on solid organ transplantation recipients"],"prefix":"10.1016","volume":"63","author":[{"given":"Juan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ru","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2024.107152_bib0001","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.21037\/apm-21-777","article-title":"Clinical features of multidrug-resistant organism infections in early postoperative solid organ transplantation in a single center","volume":"10","author":"Jin","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae","volume":"16","author":"Xu","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0003","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/lt.23374","article-title":"Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients","volume":"18","author":"Kalpoe","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0004","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0005","doi-asserted-by":"crossref","first-page":"e02329","DOI":"10.1128\/AAC.02329-16","article-title":"Nephrotoxicity in patients with or without cystic fibrosis treated with polymyxin B compared to colistin","volume":"61","author":"Crass","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0006","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13613-020-00707-2","article-title":"Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx)","volume":"10","author":"Alraish","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0007","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/22221751.2021.1937327","article-title":"Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin","volume":"10","author":"Jin","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0008","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s40121-022-00682-0","article-title":"Ceftazidime\/avibactam-based versus polymyxin b-based therapeutic regimens for the treatment of carbapenem-resistant Klebsiella pneumoniae infection in critically ill patients: a retrospective cohort study","volume":"11","author":"Zheng","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0009","doi-asserted-by":"crossref","first-page":"e02431","DOI":"10.1128\/AAC.02431-18","article-title":"Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the in vitro activities of ceftazidime-avibactam and ceftolozane-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa","volume":"63","author":"Yin","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ajt.2023.03.011","article-title":"Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae","volume":"23","author":"P\u00e9rez-Nadales","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04755-22","article-title":"Clinical outcomes and risk factors for death following carbapenem-resistant Klebsiella pneumoniae infection in solid organ transplant recipients","volume":"11","author":"Lu","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0012","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/cid\/ciab176","article-title":"Ceftazidime-avibactam use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a retrospective observational multicenter study","volume":"73","author":"Tumbarello","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0013","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/cid\/ciy492","article-title":"Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"68","author":"Tumbarello","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0014","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.2147\/IDR.S343505","article-title":"Efficacy of ceftazidime-avibactam in the treatment of carbapenem-resistant Klebsiella pneumoniae infection after kidney transplantation","volume":"14","author":"Zhang","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0015","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.2147\/IDR.S342163","article-title":"Ceftazidime-avibactam as salvage treatment for infections due to carbapenem-resistant Klebsiella pneumoniae in liver transplantation recipients","volume":"14","author":"Chen","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0016","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1093\/jac\/dky295","article-title":"Effectiveness of ceftazidime\/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae","volume":"73","author":"Sousa","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107152_bib0017","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.2147\/IDR.S394283","article-title":"Risk factors for mortality and antimicrobial regimens in pediatric intensive care unit patients with carbapenem-resistant Enterobacteriaceae infections: a six-year retrospective study","volume":"15","author":"Liu","year":"2022","journal-title":"Infect Drug Resist"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T06:28:30Z","timestamp":1714285710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0924857924000700"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107152","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of ceftazidime-avibactam in the treatment of carbapenem-resistant Klebsiella pneumoniae infections: Focus on solid organ transplantation recipients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107152"}}